HighTower Advisors’s Lucid Diagnostics LUCD Stock Holding History
Bought
Maintained
Sold
Other funds holding LUCD
HighTower Advisors's LUCD Position: Q3 2026 in Review
HighTower Advisors opened a new position in Lucid Diagnostics (LUCD) in Q3 2026: 10,012 shares worth $7.52K. The stake represents ﹤0.01% of the portfolio and ranks #3808 among its holdings.
84 funds tracked by Wall St. Rank hold LUCD as of Q3 2026.
- HighTower Advisors held 10,012 shares of Lucid Diagnostics worth $7.52K as of Q3 2026.
- Lucid Diagnostics was a new HighTower Advisors position in Q3 2026.
- Lucid Diagnostics made up ﹤0.01% of HighTower Advisors's portfolio in Q3 2026, its #3808 holding.
- 84 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q3 2026.
Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.